Meanwhile, NASH group recorded a remarkable significant increase in level of SMAD4(P < 0.001), compared to NC which was significantly corrected with Kefir treatment, compared to NASH group animals. Here, SMAD4 is linked to metabolic dysfunction-associated steatohepatitis.